Subtype
Pancreatic Carcinoma
CI-CAN-00003562Explore in graph →
489 active trials5 approved drugs31 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003562Explore in graph →
Clinical trials
1,382 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (201)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04380506 | Validations of New cut-of for the Stratification of Postoperative Complications,Drains Management(DALCUT) | unknown | N/A | 165 | Campus Bio-Medico UniversityOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT02635971 | Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 168 | Fudan UniversityOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT03840460 | A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers(PaC-MAn) | unknown | — | 200 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT04269369 | Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients | unknown | Phase 4 | 250 | Jessa HospitalOTHER | 0 | Feb 13, 2020 | clinicaltrials |
| NCT03544255 | Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues | unknown | — | 50 | Ying LvOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT04189393 | Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery(MA-PPING) | unknown | — | 60 | Radboud University Medical CenterOTHER | 0 | Dec 6, 2019 | clinicaltrials |
| NCT04164992 | Endoscopic Ultrasound Radiofrequency Ablation (EUS-RFA) of Not-resectable Pancreatic Cancer | unknown | N/A | 15 | Campus Bio-Medico UniversityOTHER | 0 | Nov 18, 2019 | clinicaltrials |
| NCT03210298 | International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)(PIPACRegis) | unknown | — | 1,000 | Sabine RhodeOTHER | 13 | Oct 8, 2019 | clinicaltrials |
| NCT02926183 | Study of NAC of GA Therapy for Patients With BRPC | unknown | Phase 2 | 60 | Wakayama Medical UniversityOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT04027088 | Effect of Preoperative Immunonutrition in Upper Digestive Tract | unknown | N/A | 178 | Complexo Hospitalario Universitario de A CoruñaOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT03951324 | Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study(VLE-IOV) | unknown | — | 40 | Innovative Digestive Health Education and Research IncOTHER | 1 | Aug 12, 2019 | clinicaltrials |
| NCT04014478 | A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain | unknown | N/A | 110 | Shanghai Golden Leaf MedTec Co. LtdINDUSTRY | 0 | Jul 10, 2019 | clinicaltrials |
| NCT03990675 | Evaluation and Comparison of the Growth Rate of Pancreatic Cancer Patient-derived Organoids | unknown | N/A | 50 | Technical University of MunichOTHER | 1 | Jun 19, 2019 | clinicaltrials |
| NCT03634332 | Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC | unknown | Phase 2 | 35 | Pancreatic Cancer Research TeamOTHER | 1 | May 7, 2019 | clinicaltrials |
| NCT02781012 | Project Survival-Prospective Biomarker Discovery | unknown | — | 436 | Pancreatic Cancer Research TeamOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03884179 | Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy | unknown | — | 58 | Sahlgrenska University HospitalOTHER | 0 | Mar 21, 2019 | clinicaltrials |
| NCT03468244 | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms | unknown | N/A | 24 | Changhai HospitalOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT03673423 | Evaluation of the Interobserver Agreement on the Resectability Status of Patients With a Pancreatic Cancer(OBTCPAN) | unknown | — | 138 | Ospedale San RaffaeleOTHER | 1 | Dec 13, 2018 | clinicaltrials |
| NCT03763214 | PTFE Stents for Treatment of Malignant Biliary Strictures | unknown | N/A | 64 | Johannes VermehrenOTHER | 1 | Dec 4, 2018 | clinicaltrials |
| NCT03210948 | Conventional Versus Elastography Targeted Endoscopic Ultrasound Fine Needle Aspiration of Solid Pancreatic Lesions | unknown | N/A | 142 | Ospedali Riuniti di FoggiaOTHER | 1 | Nov 27, 2018 | clinicaltrials |
| NCT03517332 | Circulating Tumor DNA Exposure in Peripheral Blood | unknown | — | 10,000 | Quantgene Inc.INDUSTRY | 2 | Nov 20, 2018 | clinicaltrials |
| NCT03400072 | Adapted Physical Activity in Patients With Resected Pancreatic Cancer (APACaPOp PRODIGE-56 Study): a National Multicenter Randomized Controlled Phase II Trial(APACaPOp) | unknown | N/A | 252 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Nov 19, 2018 | clinicaltrials |
| NCT03687853 | Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery | unknown | N/A | 80 | Peking University Third HospitalOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT03679910 | Evaluation of CEMIP in Pancreatic Cancer | unknown | — | 90 | Assiut UniversityOTHER | 1 | Sep 21, 2018 | clinicaltrials |
| NCT03570502 | Incidence of POPF in the Resection of the Left Pancreas With RFAT(RFATPancreas) | unknown | — | 38 | Hospital del MarOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT03513198 | Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic Cancer(PEACE) | unknown | — | 200 | University of Medicine and Pharmacy CraiovaOTHER | 0 | May 1, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT03435770 | Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms | unknown | N/A | 10 | Singapore General HospitalOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT03401827 | The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer | unknown | Phase 4 | 40 | Seoul National University HospitalOTHER | 1 | Feb 12, 2018 | clinicaltrials |
| NCT02978547 | The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma(Metformin 001) | unknown | Phase 2 | 20 | British Columbia Cancer AgencyOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02862015 | Multicenter RCT of the Clinical Effectiveness of Oncothermia With Chemotherapy in Metastatic Pancreatic Cancer Patients(Oncothermia) | unknown | Phase 2 | 100 | Seoul National University HospitalOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT03317886 | Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer | unknown | Phase 3 | 354 | Wakayama Medical UniversityOTHER | 1 | Oct 24, 2017 | clinicaltrials |
| NCT03316326 | S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer | unknown | Phase 2 | 35 | National Taiwan University HospitalOTHER | 0 | Oct 20, 2017 | clinicaltrials |
| NCT01971281 | Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA) | unknown | Phase 1 / Phase 2 | 40 | NovoCure Ltd.INDUSTRY | 2 | Sep 13, 2017 | clinicaltrials |
| NCT03251365 | Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer | unknown | Phase 2 / Phase 3 | 42 | Hospital General de Ciudad RealOTHER | 1 | Aug 16, 2017 | clinicaltrials |
| NCT03202199 | Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.(PACMI) | unknown | N/A | 125 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 26, 2017 | clinicaltrials |
| NCT01729481 | Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer(ML22774) | unknown | Phase 2 | 150 | Ludwig-Maximilians - University of MunichOTHER | 1 | Jul 19, 2017 | clinicaltrials |
| NCT03166436 | RFA for Malignant Biliary Obstruction | unknown | N/A | 140 | Institute for Clinical and Experimental MedicineOTHER_GOV | 1 | May 30, 2017 | clinicaltrials |
| NCT03063554 | EUS BD vs ERCP TP for Pancreatic Cancer(BILPAL) | unknown | N/A | 120 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT01771146 | Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer | unknown | N/A | 30 | Baylor Research InstituteOTHER | 1 | Jan 31, 2017 | clinicaltrials |
| NCT02839954 | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02587689 | Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 5, 2016 | clinicaltrials |
| NCT02607826 | Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors | unknown | N/A | 298 | University Hospital TuebingenOTHER | 0 | Oct 28, 2016 | clinicaltrials |
| NCT02929797 | Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer(AKT) | unknown | Early Phase 1 | 72 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 11, 2016 | clinicaltrials |
| NCT02707315 | A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer | unknown | Early Phase 1 | 15 | The Cooper Health SystemOTHER | 1 | Mar 14, 2016 | clinicaltrials |
| NCT02634502 | Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis | unknown | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT02133079 | Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96 | unknown | Phase 1 / Phase 2 | 20 | Cure&Sure Biotech Co., LTDINDUSTRY | 1 | Dec 11, 2015 | clinicaltrials |
| NCT01879878 | Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial](POUDER) | unknown | N/A | 40 | Heidelberg UniversityOTHER | 1 | May 28, 2015 | clinicaltrials |
| NCT02285660 | Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition | unknown | N/A | — | The Leeds Teaching Hospitals NHS TrustOTHER | 1 | Nov 7, 2014 | clinicaltrials |
| NCT01411072 | Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer | unknown | N/A | 20 | AHS Cancer Control AlbertaOTHER | 1 | Oct 3, 2014 | clinicaltrials |
Data updated 23 days agoSource updated May 8, 2020source: clinicaltrials